指南与共识胸部CT

与指南不一致的肺癌筛查:新出现的需求及所给适应症

Guideline-Discordant Lung Cancer Screening: Emerging Demand and Provided Indications.
指南 / 共识 · J Am Coll Radiol · 2020-09-06

研究分析某学术医学中心2018年11月至2019年12月触发BPA警报的肺癌筛查CT订单,发现42例(占全部筛查患者1.9%)为指南不一致筛查,最常见适应症为肺癌家族史(21.4%),患者和转诊提供者对癌症风险升高的感知驱动了此类使用。

要点

  • 指南不一致肺癌筛查占全部筛查患者的1.9%(42/2248),其中45.2%不符合美国任何指南。
  • 最常见的不一致适应症为肺癌家族史(21.4%),其次为年龄、吸烟史不符合标准。
  • 患者和转诊提供者对癌症风险升高的感知是驱动指南不一致筛查的主要因素。

诊断标准与关键数值

  • 指南不一致肺癌筛查占全部筛查患者的1.9%(42/2248)。
  • 42.9%(18/42)年龄<54岁或>77岁,14.3%(6/42)从不吸烟,40.5%(17/42)戒烟>15年,31%(13/42)吸烟<30包年。
  • 45.2%(19/42)不符合所有美国指南;最常见适应症为肺癌家族史(21.4% [9/42])。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: It is unclear whether patients and providers have started to knowingly request lung cancer screening (LCS) outside US guidelines and insurance coverage for risk factors besides a history of heavy smoking. The authors analyzed their institution's best practices advisory (BPA) clinical decision support system to determine whether providers knowingly order guideline-discordant LCS and the indications given.

METHODS: CT examinations ordered for LCS at an academic medical center that triggered BPA alerts from November 2018 to December 2019 were reviewed. Alerts were triggered by attempts to order examinations outside Medicare coverage, which resembles most US guidelines. Providers can override alerts to order the examinations. Primary outcomes were the number of examinations performed using orders with overridden BPA alerts and indications given. Qualitative exploratory and directed content analyses identified motivators and decision-making processes that drove guideline-discordant screening use.

RESULTS: Forty-two patients underwent guideline-discordant LCS, constituting 1.9% of all patients screened (42 of 2,248): 42.9% (18 of 42) were <54 or >77 years old, 14.3% (6 of 42) had never smoked, 40.5% (17 of 42) had quit >15 years earlier, and 31% (13 of 42) had smoked <30 pack-years; 45.2% (19 of 42) fell outside all US guidelines. The most common indication was a family history of lung cancer (21.4% [9 of 42]). Perceptions of elevated cancer risk from both patients and referring providers drove guideline-discordant screening use.

CONCLUSIONS: Referring providers knowingly ordered screening CT examinations outside Medicare coverage and US guidelines, including for never smokers, for indications including a family history of lung cancer. LCS programs may need tailored strategies to guide these patients and providers, such as help with cancer risk assessment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Wang GX, Neil JM, Fintelmann FJ, et al. Guideline-Discordant Lung Cancer Screening: Emerging Demand and Provided Indications. J Am Coll Radiol. 2020. PMID: 32905787. doi:10.1016/j.jacr.2020.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。